Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids

Clinical Cancer Research

Volumn 5, Issue 2, 1999, Pages 431-437

  Sun, Shi Yong ^a   Kurie, Jonathan M ^a   Yue, Ping ^a   Dawson, Marcia I ^c   Shroot, Braham ^b   Chandraratna, Roshantna A S ^d   Hong, Waun K ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Galderma R and D   (France)

^c SRI INTERNATIONAL   (United States)

^d Retinoid Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)BENZO[B]THIOPHENE 6 CARBOXYLIC ACID; 4 [1 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CYCLOPROPYL]BENZOIC ACID; 4 [2 METHYL 1 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; 4 [7 ADAMANTYL 6 [(2 METHOXYETHOXY)METHOXY] 2 NAPHTHYL]BENZOIC ACID; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ADAPALENE; BEXAROTENE; CD 2314; CD 2325; CD 2366; CD 336; CD 666; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE; RETINOID X RECEPTOR; SR 11203; SR 11234; SR 11236; SR 11238; SR 11254; SR 11363; SR 11364; SR 3985; TAMIBAROTENE; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; LUNG CARCINOMA; PRECANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BRONCHI; BRONCHIAL NEOPLASMS; CELL DIVISION; CHEMOPREVENTION; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; HUMANS; LUNG NEOPLASMS; PRECANCEROUS CONDITIONS; RECEPTORS, RETINOIC ACID; RETINOIDS; TRETINOIN;

EID: 0033011484     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1998. CA Cancer J. Clin., 48: 6-29, 1998.
2. Smith, M. A., Parkinson, D. R., Cheson, B. D., and Friedman, M. A. Retinoids in cancer therapy. J. Clin. Oncol., 10: 839-864, 1992.
3. Benner, S. E., Lippman, S. M., and Hong, W. K. Current status of retinoid chemoprevention of lung cancer. Oncology, 9: 205-210, 1995.
4. Hong, W. K., and Itri, L. M. Retinoids and human cancer. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 597-658. New York: Raven Press, 1994.
5. Gudas, L. J., Sporn, M. B., and Roberts, A. B. Cellular biology and biochemistry of the retinoids. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp.443-520. New York: Raven Press, 1994.
6. Lotan, R. Cellular biology of the retinoids. In: L. Degos, and D. R. Parkinson (eds.), Retinoids in Oncology, pp. 27-42, Berlin: Springer, 1995.
7. Hong, W., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P., and Strong, S. 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
8. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. S., Kramer, A. M., Lotan, R., Peters, L. L., Dimery, I. W., Brown, B. W., and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
9. Pastorino, U., Infante, M., Maioli, M., Chiesa, G., Buyse, M., Firket, P., Rotmentz, N., Clerici, M., Soresi, E., Valente, M., Belloni, P., and Ravasi, G. Adjuvant treatment of stage I lung cancer with high dose vitamin A. J. Clin. Oncol., 11: 1216-1222, 1993.
10. Warrell, R. P., Jr., Frankel, S. P., Miller, W. H., Jr., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas. R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gorden, M. S., and Dmitrovsky, E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med., 324: 1385-1393, 1991.
11. Huang, M. E., Ye, Y. C., Chen, S. R., Chai, J. R., Lu, J. X., Zhao, L., Gu, L. J., and Wang, Z. Y. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72: 567-572, 1988.
12. Castaigne, S., Chomienne, C., Danie, M. T., Ballerini, P., Berger, R., Fenaux, P., and Degos, L. All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 76: 1704-1709, 1990.
13. Wu, R., Martin, W., Robinson, C., St. George, J., Plopper, C., Kurlan, G., Last, J., Cross, C., McDonald, R., and Boucher, R. Expression of mucin synthesis and secretion in human tracheobronchial epithelial cells grown in culture. Am. J. Respir. Cell. Mol. Biol., 3: 467-478, 1990.
14. Jetten, A. M., Nervi, C., and Vollberg, T. M. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. J. Natl. Cancer Inst. Monogr., 13: 93-100, 1992.
15. Saffiotti, U., Montesano, R., Sellakumar, A., and Borg, S. Experimental cancer of the lung: inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer (Phila.), 20: 857-864, 1967.
16. Moon, R. C., Mehta, R. G., and Rao, K. J. V. N. Retinoids and cancer in experimental animals. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 573-595. New York: Raven Press, 1994.
17. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. The retinoid receptors. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 319-349. New York: Raven Press, 1994.
18. Chambon, P. The retinoid signaling pathway: molecular and genetic analysis. Semin. Cell Biol., 5: 115-125, 1994.
19. Pfahl, M. Vertebrate receptors: molecular biology, dimerization and response elements. Semin. Cell Biol., 5: 95-103, 1994.
20. Delescluse, C., Cavey, M. T., Martin, B., Bernard, B. A., Reichert, U., Maignan, J., Darmon, M., and Shroot, B. Selective high affinity retinoic acid receptor α or β-γ ligands. Mol. Pharmacol., 40: 556-562, 1991.
21. Lehmann, J. M., Dawson, M. I., Hobbs, P. D., Husmann, M., and Pfahl, M. Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res., 51: 4804-4809, 1991.
22. Lehmann, J. M., Jong, L., Fanjul, A., Cameron, J. F., Lu, X. P., Haefner, P., Dawson, M. I., and Pfahl, M. Retinoids selective for retinoid X receptor response pathways. Science (Washington DC), 258: 1944-1946, 1992.
23. Apfel, C., Crettaz, M., and LeMotte, P. Differential binding and activation of synthetic retinoids to retinoic acid receptors. In: G. Morriss-Kay (ed.), Retinoids in Normal Development and Teratogenesis, pp. 65-74. Oxford: Oxford University Press, 1992.
24. Bernard, B. A., Bernardon, J-M., Delescluse, C., Martin, B., Lenoir, M-C., Maignan, J., Charpentier, B., Pilgrim, W. R., Reichert, U., and Shroot, B. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem. Biophys. Res. Commun., 186: 977-983, 1992.
25. Dawson, M. I., Hobbs, P. D., Stein, R. B., Berger, T. S., and Heyman, R. A. Interaction of retinoids with retinoic acid nuclear receptor isoforms. In: M. A. Livrea, and L. Packer (eds.), Retinoids: Progress in Research and Clinical Applications, pp. 205-222. New York: Marcel Dekker, 1992.
26. Keidel, S., Szardenings, M., and Mueller, W. H. In vivo biological activity of retinoids partially correlates to their affinity to recombinant retinoic acid receptor α and recombinant-cellular retinoic-acid-binding protein I. Eur. J. Biochem., 212: 13-26, 1993.
27. Boehm, M. F., Zhang, L., Badea, B. A., White, S. K., Mais, D. E., Berger, E., Suto, C. M., Goldman, M. E., and Heyman, R. A. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J. Med. Chem., 37: 2930-2941, 1994.
28. Fanjul, A., Dawson, M. I., Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X-P., and Pfahl, M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (Lond. ), 372: 107-110, 1994.
29. Dawson, M. I., Jong, L., Hobbs, P. D., Cameron, J. F., Chao, W-R., Pfahl, M., Lee, M-O., Shroot, B., and Pfahl, M. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J. Med. Chem., 38: 3368-3383, 1995.
30. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene, 11: 493-504, 1995.
31. Geradts, J., Chen, J-Y., Russell, E. K., Yankaskas, J. R., Nieves, L., and Minna, J. D. Human lung cancer cells exhibit resistance to retinoic acid treatment. Cell Growth Differ., 4: 799-809, 1993.
32. Kim, Y-H., Dohi, D. F., Han, G. R., Zou, C-P., Oridate, N., Walsh., G. L., Nesbitt, J. C., Xu. X-C., Hong, W. K., Lotan, R., and Kurie, J. M. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res., 55: 5603-5610, 1995.
33. Klein-Szanto, A. J. P., Iizasa, T., Momiki, S., Garcia-Palazzo, I., Caamano, J., Metcalf, R., Welsh, J., and Harris, C. C. A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA., 89: 6693-6697, 1992.
34. Reddel, R. R., Ke, Y., Gerwin, B. I., McMenamin, M. G., Lechner, J. F., Su, R. T., Brash, D. E., Park, J. B., Rhim, J. S., and Harris, C. C. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 early region genes. Cancer Res., 48: 1904-1909, 1988.
35. Johnson, A. T., Klein, E. S., Gillett, S. J., Wang, L., Song, T. K., Pino, M. E., and Chandraratna, R. A. S. Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem., 38: 4764-4767, 1996.
36. Sun, S-Y., Yue, P., Shroot, B., Michel, S., Dawson, M. I., Lamph, W. W., Heyman, R. A., Teng, M., Chandraratna, R. A. S., Shudo, K., Hong W. K., and Lotan, R. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res., 57: 4931-4939, 1997.
37. Sun, S-Y., Yue, P., Shroot, B., Hong W. K., and Lotan, R. Induction of apoptosis in human non-small cell lung carcinoma cells by a novel synthetic retinoid CD437. J. Cell Physiol.. 173: 279-284, 1997.
38. Dawson, M. I., Elena, E., Kizaki, M., Chen, D-L., Pakkala, S., Kerner, B., and Koeffler, H. P. Myeloid differentiation mediated through retinoic acid receptor/retinoid X receptor (RXR) not RXR/RXR pathway. Blood, 84: 446-452, 1994.
39. Clifford, J., Chiba, H., Sobieszczuk, D., Metzger, D., and Chambon, P. RXRα-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J., 15: 4142-4155, 1996.
40. Lotan, R., Dawson, M. I., Zou, C-C., Jong, L., Lotan, D., and Zou, C-P. Enhanced efficacy of combinations of retinoic acid-and retinoid X receptor-selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res., 55: 232-236, 1995.
41. Roy, B., Taneja, R., and Chambon, P. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RAR-α)-RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell. Biol., 15: 6481-6487, 1995.
42. Szarka, C. E., Grana, G., and Engstorm, P. Chemoprevention of cancer. Curr. Probl. Cancer, 18: 1-80, 1994.
43. Lotan, R. Retinoids in cancer chemoprevention. FASEB J., 10: 1031-1039, 1996.
44. Kliewer, S. A., Umesono, K., Mangelsdorf, D. J., and Evans, R. M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signaling. Nature (Lend.), 355: 446-449, 1992.
45. Yu, V. C., Delsert, C., Andersen, B., Holloway, J. M., Devary, O. V., Naar, A. M., Kim S. Y., Boutin, J-M., Glass, C. K., and Rosenfeld, M. G. RXR β: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response element. Cell, 67: 1251-1266, 1991.
46. Zhang, X. K., Hoffmann, B., Tran, P. B-V., Graupner, G., and Pfahl, M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptor. Nature (Lond.), 355: 441-446, 1992.
47. Westin, S., Kurokawa, R., Nolte, R. T., Wisely, G. B., McInerney, E. M., Rose, D. W., Milburn, M. V., Rosenfeld, M. G., and Glass, C. K. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature (Lond.), 395: 199-200, 1998.
48. Kazmi, S. M., Plante, R. K., Visconti, V., and Lau, C. Y. Comparison of N-(4-hydroxylphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Cancer Res., 56: 1056-1062, 1996.
49. Fanjul, A. N., Delia, D., Pierotti, M. A., Rideout, D, Qiu, J., and Pfahl, M. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. Biol. Chem., 271: 22441-22446, 1996.
50. Pfahl, M. Nuclear receptor/AP-1 interaction. Endocrine Rev., 14: 651-658, 1992.